Pharmacological Approaches for BRCA1/2 Related Breast and Ovarian Cancer: Preclinical Studies and Early Clinical Trials

Publisher： Bentham Science Publishers

E-ISSN： 1875-6581|8|1|104-110

ISSN： 1573-4048

Source： Current Women's Health Reviews, Vol.8, Iss.1, 2012-02, pp. : 104-110

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Influence of BRCA1/BRCA2 Mutations on Toxicity Related to Chemotherapy and Radiotherapy in Early Breast Cancer Patients

By  

Oncology, Vol. 85, Iss. 5, 2013-11 ,pp. : 278-282

Karger

Access to resources Recommend Favorite

Management of early-onset breast cancer and BRCA1 or BRCA2 status

By Haffty B.G.  

The Lancet, Vol. 360, Iss. 333, 2002-08 ,pp. : 640-641

Elsevier

Access to resources Recommend Favorite

Management of early-onset breast cancer and BRCA1 or BRCA2 status

By Vaidya J.S.   Baum M.  

The Lancet, Vol. 360, Iss. 333, 2002-08 ,pp. : 640-640

Elsevier

Access to resources Recommend Favorite

Clinical implications of the breast cancer susceptibility genes BRCA1 and BRCA2

By Narod Steven A  

Women's Health, Vol. 1, Iss. 1, 2005-07 ,pp. : 27-34

Future Medicine

Access to resources Recommend Favorite

Molecular Rationales for Signal Transduction Therapy and Chemoprevention of BRCA1-Related Breast and Ovarian Tumours

By  

Current Signal Transduction Therapy, Vol. 2, Iss. 2, 2007-05 ,pp. : 165-173

Bentham Science Publishers

Access to resources Recommend Favorite